Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nephros (NEPH) Operating Expenses (2016 - 2025)

Nephros (NEPH) has 16 years of Operating Expenses data on record, last reported at $2.6 million in Q3 2025.

  • For Q3 2025, Operating Expenses rose 33.87% year-over-year to $2.6 million; the TTM value through Sep 2025 reached $9.9 million, up 7.21%, while the annual FY2024 figure was $8.7 million, 12.81% down from the prior year.
  • Operating Expenses reached $2.6 million in Q3 2025 per NEPH's latest filing, up from $2.5 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $2.7 million in Q4 2023 and bottomed at $1.3 million in Q4 2021.
  • Average Operating Expenses over 5 years is $2.3 million, with a median of $2.4 million recorded in 2021.
  • Peak YoY movement for Operating Expenses: tumbled 34.98% in 2021, then skyrocketed 67.58% in 2022.
  • A 5-year view of Operating Expenses shows it stood at $1.3 million in 2021, then surged by 67.58% to $2.2 million in 2022, then increased by 21.25% to $2.7 million in 2023, then dropped by 19.18% to $2.2 million in 2024, then grew by 20.53% to $2.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Expenses were $2.6 million in Q3 2025, $2.5 million in Q2 2025, and $2.6 million in Q1 2025.